Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3897066010 | Ubrogepant (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3897067018 | Ubrogepant | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ubrogepant | Is a | Heterocyclic compound | true | Inferred relationship | Existential restriction modifier | ||
| Ubrogepant | Has disposition | Calcitonin gene-related peptide receptor antagonist | true | Inferred relationship | Existential restriction modifier | ||
| Ubrogepant | Is a | Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only ubrogepant (medicinal product) | Has active ingredient | True | Ubrogepant | Inferred relationship | Existential restriction modifier | 1 |
| Product containing ubrogepant in oral dose form (medicinal product form) | Has active ingredient | True | Ubrogepant | Inferred relationship | Existential restriction modifier | 1 |
| Product containing ubrogepant (medicinal product) | Has active ingredient | True | Ubrogepant | Inferred relationship | Existential restriction modifier | 1 |
| Product containing only ubrogepant in oral dose form (medicinal product form) | Has active ingredient | True | Ubrogepant | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets
FHIR